336 results on '"Katagiri, Yuki"'
Search Results
52. Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study
53. Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication.
54. Vulnerable plaques and patients: state-of-the-art
55. WORKPLACE REFORM WITH CHANGING MANAGEMENT THROUGH THE USER PARTICIPATION WORKSHOP : THE CASE STUDY OF SEIYO CITY OFFICE
56. Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data
57. Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial
58. The influence of implantation techniques on lesion oriented-outcomes in Absorb BVS and Xience EES lesions treated in routine clinical practice at complete three year follow-up: AIDA trial QCA substudy
59. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with three-vessel disease:2-year follow-up of the SYNTAX II study
60. Post-implantation shear stress assessment: an emerging tool for differentiation of bioresorbable scaffolds
61. Site vs. core laboratory variability in computed tomographic angiography-derived SYNTAX scores in the SYNTAX III trial.
62. The Long-Term Impact of Post-Procedural Asymmetry and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
63. Site versus Core Laboratory SYNTAX score variability
64. Assessment of Heart Team's Treatment Decision Variability: Insights from the SYNTAX III Revolution trial
65. TCT-172 Hemodynamic Analysis of New Version Mirage Bioresorbable Scaffold and Metallic Ultimaster Stent: A New Era Begins With Shear Stress Analysis in Stent Assessment
66. TCT-170 Endothelial Shear Stress and Vascular Remodeling in Bioresorbable Scaffold and Metallic Stent
67. TCT-186 Preclinical Evaluation of a Novel Thin-Strut PLLA Bioresorbable Scaffold in Porcine Coronary Artery at 6-Month Follow-Up
68. TCT-179 The Influence of Increasing Stent Length on Outcomes in Absorb BVS or Xience EES-Treated Patients in Routine Clinical PCI Practice: AIDA Trial Substudy
69. TCT-111 Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for Three Vessel Disease
70. TCT-183 The Impact of Atherosclerotic Plaque Type on Strut Penetration and Local Hemodynamics in Bioresorbable Scaffolds
71. Expert recommendations on the assessment of wall shear stress in human coronary arteries: existing methodologies, technical considerations, and clinical applications
72. Acute and long-term relocation of minimal lumen area after bioresorbable scaffold or metallic stent implantation
73. Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
74. Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study
75. A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial
76. Early strut protrusion and late neointima thickness in the Absorb bioresorbable scaffold: a serial wall shear stress analysis up to five years
77. Bearing Strength Formula of Roughened Concrete Considering Vertical Projection Area
78. The impact of plaque type on strut embedment/protrusion and shear stress distribution in bioresorbable scaffold
79. Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study
80. How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials
81. TCTAP A-063 Endothelial Shear Stress and Vascular Remodeling in Bioresorbable Scaffold and Metallic Stent in the ABSORB II Trial
82. TCTAP A-064 The Impact of Plaque Type on Strut Embedment/Protrusion and Shear Stress Distribution in Bioresorbable Scaffold
83. Feasibility of planning coronary artery bypass grafting based only on coronary computed tomography angiography and CT-derived fractional flow reserve: a pilot survey of the surgeons involved in the randomized SYNTAX III Revolution trial
84. LONG-TERM SAFETY OF TICAGRELOR MONOTHERAPY IN PATIENTS UNDERGOING PCI FOR STABLE CORONARY ARTERY DISEASE IN THE GLOBAL LEADERS STUDY: IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
85. LONG-TERM TICAGRELOR MONOTHERAPY IN ELDERLY PATIENTS UNDERGOING PCI IN THE GLOBAL LEADERS STUDY
86. PREDICTIVE ABILITY OF THE PARIS RISK SCORE IN ALL-COMERS PATIENTS UNDERGOING PCI WITH DRUG ELUTING STENTS: EXTERNAL VALIDATION IN THE GLOBAL LEADERS STUDY
87. CORE LABORATORY ASSESSMENT OF NON-FATAL Q-WAVE MYOCARDIAL INFARCTION IN THE GLOBAL LEADERS TRIAL: METHODS AND FINDINGS
88. Serial Optical Coherence Tomography at Baseline, 7 Days, and 1, 3, 6 and 12 Months After Bioresorbable Scaffold Implantation in a Growing Porcine Model
89. Mechanical properties and performances of contemporary drug-eluting stent: focus on the metallic backbone
90. Joint consensus on the use of OCT in coronary bifurcation lesions by the European and Japanese bifurcation clubs
91. Impact of post‐procedural minimal stent area on 2‐year clinical outcomes in the SYNTAX II trial
92. A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial
93. Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
94. The impact of plaque type on strut embedment/protrusion and shear stress distribution in bioresorbable scaffold.
95. Post-implantation shear stress assessment: an emerging tool for differentiation of bioresorbable scaffolds
96. Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease
97. Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
98. TCT-112 Patient-oriented clinical outcomes and net adverse cardiovascular event in the Global Leaders trial
99. TCT-430 In vitro and preclinical evaluation of a thin-strut bioresorbable scaffold: results from bench testing and acute phase study in a non-atherosclerotic porcine model.
100. TCT-673 Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A Sub-analysis of the SYNTAX II study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.